Biography
Professional Background
Dr Alptekin Aydin graduated with First-Class Honours in Psychology from Istanbul University before completing a postgraduate Master's degree at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, where he trained in Neurological and Pharmacological Substance Addiction. He subsequently obtained his International Clinical TMS Certification from Maastricht University, accredited by the European Accreditation Council for Continuing Medical Education (EACCME).
His doctoral research (DClinPsy) at Atlantic International University (AIU), Honolulu, USA, included a published study on "Assessing the Impact of tDCS Treatment Over the Dorsolateral Prefrontal Cortex (DLPFC) on Social Communication in Children with ASD". He also holds an equivalence certificate from the Higher Education Council in Turkey.
In 2018, Dr Aydin developed QPAN® (QEEG-guided Personalised NeuroMap®-based Neuromodulation Therapy) — an advanced therapeutic system integrating QEEG functional brain mapping with our proprietary NeuroMap® technology. Since its development, QPAN® has supported thousands of individuals, with the majority of patients and families reporting meaningful improvements in their clinical outcomes.
"Accurate diagnosis is not merely the beginning of treatment; it is often the treatment itself. When patients truly understand what is happening in their brain, they become active participants in their own recovery."
— Dr Alptekin Aydin
Dr Aydin holds additional certifications in QEEG Reporting and Advanced EEG Interpretation (Florida, USA), and Expert Witness for Civil Law (Cardiff School of Law and Politics, Bond Solon).